首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1563396

人工血管市場規模、佔有率、成長分析、按原料、按適應症、按最終用戶、按地區 - 行業預測，2024-2031 年

Vascular Grafts Market Size, Share, Growth Analysis, By Raw Material, By Indication, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月26日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球血管移植市場規模約15億美元，預測期內（2024-2031年）複合年成長率為7.2%，從2023年的16億美元增加至2031年的28億美元。。

由於心血管疾病盛行率上升、醫療技術進步以及世界人口老化，全球人造血管市場正在經歷顯著成長。糖尿病、高血壓和肥胖症的增加導致血管疾病的增加，從而增加了對血管移植物的需求。合成移植物和生物工程移植物等創新正在提高血管手術的成功率，進一步推動市場發展。微創手術技術的使用也縮短了恢復時間並減少了併發症。此外，末期腎臟病的增加增加了對透析通路手術中使用的血管移植物的需求。新興市場不斷上漲的醫療成本以及政府旨在改善醫療基礎設施的措施也有助於市場擴張。然而，血管移植物（尤其是先進的生物工程類型）的高成本以及血栓症和感染疾病等併發症的風險等挑戰限制了市場的成長。從地理位置來看，北美由於其先進的醫療基礎設施、高昂的醫療成本以及大量患有血管疾病的患者而在血管移植市場佔據主導地位。然而，由於醫療保健投資的增加、意識的提高和醫療基礎設施的改善，亞太地區預計將成長最快。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Medtronic
Terumo
CR Bard
B. Braun Melsungen AG
Cardinal Health
Endologix
Lemaitre Vascular
Cook Medical
Maquet
Gore Medical

簡介目錄

Product Code: SQMIG35A2177

Global Vascular Grafts Market size was valued at around 1.5 billion in 2022 and is expected to rise from USD 1.6 billion in 2023 to reach a value of USD 2.8 billion by 2031, at a CAGR of 7.2% over the forecast period (2024-2031).

The Global Vascular Grafts Market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases, advancements in medical technology, and an aging global population. The increasing cases of diabetes, hypertension, and obesity have contributed to a rise in vascular disorders, which has, in turn, escalated the demand for vascular grafts. Technological innovations such as synthetic and bio-engineered grafts are improving the success rates of vascular surgeries, further boosting the market. The use of minimally invasive surgical techniques is also gaining traction, leading to quicker recovery times and fewer complications. Moreover, an increase in end-stage renal diseases has led to a higher demand for vascular grafts used in dialysis access surgeries. The rise in healthcare expenditure in emerging markets, alongside government initiatives aimed at improving healthcare infrastructure, is also contributing to market expansion. However, challenges such as high costs of vascular grafts, especially advanced and bio-engineered types, and risks of complications such as thrombosis and infection are limiting market growth. Geographically, North America dominates the vascular grafts market due to its advanced healthcare infrastructure, high healthcare expenditure, and a large patient population suffering from vascular diseases. However, the Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare investments, growing awareness, and improving medical infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Grafts Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vascular Grafts Market Segmental Analysis

Global Vascular Grafts Market is segmented by Raw Material, Indication, End User, and region. Based on Raw Material, the market is segmented into Polyester Grafts, ePTFE, Polyurethane Grafts, and Biosynthetic Grafts. Based on Indication, the market is segmented into Endovascular Aneurysm Repair, Abdominal Aortic Aneurysms Repair, Thoracic Aortic Aneurysm Repair, Peripheral Vascular, and Hemodialysis Access. Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Vascular Grafts Market

One of the primary drivers of the vascular grafts market is the alarming rise in cardiovascular diseases (CVDs) globally. Sedentary lifestyles, poor dietary habits, and increasing smoking and alcohol consumption have contributed to a higher prevalence of CVDs, including coronary artery disease, aneurysms, and peripheral arterial disease. As CVDs often result in blocked or weakened arteries, vascular grafts become essential to restoring blood flow and preventing severe complications like heart attacks or strokes. The aging population also contributes to this trend, as older adults are more susceptible to vascular diseases. For instance, the World Health Organization (WHO) estimates that cardiovascular diseases account for around 32% of global deaths, emphasizing the need for timely surgical intervention. This rising burden of cardiovascular diseases is driving the demand for vascular grafts, as they play a critical role in bypass surgeries, vascular repairs, and hemodialysis access for patients with end-stage renal disease, further fueling market growth.

Restraints in the Global Vascular Grafts Market

One of the major restraints in the vascular grafts market is the high cost associated with advanced graft materials and surgical procedures. Synthetic and bio-engineered grafts, while offering better outcomes in terms of biocompatibility and longevity, tend to be significantly more expensive than traditional graft materials. The production processes for these advanced grafts involve complex biotechnology and require stringent quality control, leading to higher costs. This financial barrier can be particularly challenging in low- and middle-income countries, where healthcare budgets are limited, and patients may struggle to afford these treatments. Additionally, insurance coverage for vascular graft surgeries may not always be comprehensive, further limiting access to advanced treatments. The high cost can also deter healthcare providers from adopting newer technologies, preferring more traditional, affordable options, despite the clinical benefits offered by cutting-edge vascular graft solutions. This price sensitivity acts as a constraint, slowing the widespread adoption of advanced vascular grafts, especially in resource-limited settings.

Market Trends of the Global Vascular Grafts Market

A notable trend in the vascular grafts market is the growing shift towards bioengineered and biodegradable grafts, driven by the increasing need for biocompatible and long-lasting solutions. Traditional synthetic grafts, such as those made from PTFE (polytetrafluoroethylene) or Dacron, are effective but pose risks of infection, rejection, or thrombosis over time. In response, researchers and manufacturers are focusing on developing grafts that can better integrate with the body's tissues, promoting natural healing and reducing complications. Bioengineered grafts, often made from collagen, elastin, or decellularized tissues, mimic the natural properties of blood vessels, improving their compatibility and performance in vascular surgeries. Biodegradable grafts, on the other hand, are designed to degrade over time, allowing the body's own tissues to regenerate and take over the graft's function. This trend towards more natural, tissue-friendly materials is expected to reduce the risk of long-term complications and improve patient outcomes, making it a key area of focus for future advancements in the vascular grafts market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Patent Analysis
Raw Material Analysis

Vascular Graft Market, By Raw Material

Market Overview
Polyester Grafts
Eptfe Grafts
Polyurethane Grafts
Biosynthetic Grafts

Vascular Graft Market, By Indication

Market Overview
Endovascular Aneurysm Repair
- Abdominal Aortic Aneurysms Repair
- Thoracic Aortic Aneurysm Repair
Peripheral Vascular Repair
Hemodialysis Access

Vascular Graft Market, By End User

Market Overview
Hospitals
Ambulatory Surgical Centers

Vascular Graft Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C. R. Bard
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lemaitre Vascular
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maquet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gore Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments